Supplemental Figure 3 from Hepatitis B Virus X Protein (hbx) is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence
crossref（2023）
摘要
Supplemental Figure 3. HBx is associated with bortezomib resistance in HBV/HBx-related HCC cells.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要